Table 2.
Healthy controls | Patients HAMD ≤ 15 | Patients HAMD > 15 | ||||
---|---|---|---|---|---|---|
pgACC | AI | pgACC | AI | pgACC | AI | |
Creatine (Cr) | 5.64 ± 1.6 | 3.88 ± 2.94 | 4.9 ± 1.6 | 3.62 ± 1.92 | 5.65 ± 1.66 | 4.79 ± 1.53 |
Glutamate/Cr | 1.06 ± 0.08 | 0.82 ± 0.61 | 1.15 ± 0.11 | 1.01 ± 0.45 | 0.98 ± 0.09 | 1.06 ± 0.19 |
myo-Inositole/Cr | 0.71 ± 0.14 | 0.49 ± 0.34 | 0.71 ± 0.07 | 0.58 ± 0.31 | 0.67 ± 0.09 | 0.70 ± 0.15 |
NAA/Cr | 1.04 ± 0.15 | 0.85 ± 0.59 | 1.06 ± 0.15 | 1.03 ± 0.44 | 1.06 ± 0.13 | 1.11 ± 0.14 |
Glx/Cr | 1.29 ± 0.11 | 0.92 ± 0.69 | 1.47 ± 0.19 | 1.21 ± 0.54 | 1.2 ± 0.2 | 1.19 ± 0.2 |